Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mai, Kakimoto"'
Autor:
Toru Hosoi, Shinsuke Ino, Fumie Ohnishi, Kenichi Todoroki, Michiko Yoshii, Mai Kakimoto, Christa E. Müller, Koichiro Ozawa
Publikováno v:
Immunity, Inflammation and Disease, Vol 6, Iss 1, Pp 97-105 (2018)
Abstract Introduction Mast cells play an important role in allergic responses. Methods We herein demonstrated the mechanisms of inhibitory effect of adenine on IgE/antigen‐induced degranulation and TNF‐α release in mast cells. Results We found t
Externí odkaz:
https://doaj.org/article/c8e2e2edd5ce4754ad76e2414bb0869b
Autor:
Shusei Yamamoto, Ikumi Sato, Moe Fujii, Mai Kakimoto, Koki Honma, Sora Kirihara, Hinako Nakayama, Taketo Fukuoka, Satoru Tamura, Minoru Ueda, Satoshi Hirohata, Shogo Watanabe
Publikováno v:
Canadian Journal of Physiology and Pharmacology.
The liver X receptor (LXR) can enhance cholesterol transporters, which could remove excess cholesterol from foam cells in atheromas. LXR has two subtypes: LXRα, which aggravates hepatic lipid accumulation, and LXRβ, which does not. In 2018, ouabage
Autor:
Mai Kakimoto, Moe Fujii, Ikumi Sato, Koki Honma, Hinako Nakayama, Sora Kirihara, Taketo Fukuoka, Shang Ran, Satoshi Hirohata, Kazuya Kitamori, Shusei Yamamoto, Shogo Watanabe
Publikováno v:
Journal of Applied Biomedicine.
Autor:
Shogo Watanabe, Moe Fujii, Mai Kakimoto, Ikumi Sato, Koki Honma, Sora Kirihara, Hinako Nakayama, Taketo Fukuoka, Satoshi Hirohata, Kazuya Kitamori, Shang Ran, Shusei Yamamoto
Publikováno v:
Current Nutrition & Food Science. 19
Background: Nonalcoholic steatohepatitis (NASH) is well associated with an increased risk of cardiovascular disease (CVD), regardless of risk factors for metabolic syndrome. However, intermediary factors between NASH and CVD remain unknown. In recent
Publikováno v:
Journal of Pharmacological Sciences, Vol 131, Iss 4, Pp 292-295 (2016)
A pharmacological approach to ameliorate Alzheimer's disease (AD) has not yet been established. In the present study, we investigated the pharmacological characteristics of the recently identified memory-enhancing compound, ISRIB for the amelioration
Externí odkaz:
https://doaj.org/article/afa03c346a17404ca04b281fd5ac1f72
Autor:
Shusei Yamamoto, Koki Honma, Moe Fujii, Mai Kakimoto, Sora Kirihara, Hinako Nakayama, Kazuya Kitamori, Ikumi Sato, Satoshi Hirohata, Shogo Watanabe
Publikováno v:
Annals of Anatomy - Anatomischer Anzeiger. 249:152104
Autor:
Ikumi Sato, Shusei Yamamoto, Mai Kakimoto, Moe Fujii, Koki Honma, Shota Kumazaki, Mami Matsui, Hinako Nakayama, Sora Kirihara, Shang Ran, Shinichi Usui, Ryoko Shinohata, Kazuya Kitamori, Satoshi Hirohata, Shogo Watanabe
Publikováno v:
Pharmacological reports : PR. 74(4)
Non-alcoholic steatohepatitis (NASH) is a progressive subtype of non-alcoholic fatty liver disease (NAFLD) that is closely related to cardiovascular disease (CVD). Nitric oxide (NO) plays a critical role in the control of various biological processes
Autor:
Ikumi, Sato, Shusei, Yamamoto, Mai, Kakimoto, Moe, Fujii, Koki, Honma, Shota, Kumazaki, Mami, Matsui, Hinako, Nakayama, Sora, Kirihara, Shang, Ran, Satoshi, Hirohata, Shogo, Watanabe
Publikováno v:
Journal of Electromyography and Kinesiology. 62:102627
The mechanomyogram (MMG) is a signal measured by various vibration sensors for slight vibrations induced by muscle contraction, and it reflects the muscle force during electrically induced-contraction or until 60%-70% maximum voluntary contraction, s
Autor:
Christa E. Müller, Koichiro Ozawa, Kenichi Todoroki, Fumie Ohnishi, Michiko Yoshii, Shinsuke Ino, Toru Hosoi, Mai Kakimoto
Publikováno v:
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease, Vol 6, Iss 1, Pp 97-105 (2018)
Immunity, Inflammation and Disease, Vol 6, Iss 1, Pp 97-105 (2018)
Introduction Mast cells play an important role in allergic responses. Methods We herein demonstrated the mechanisms of inhibitory effect of adenine on IgE/antigen-induced degranulation and TNF-α release in mast cells. Results We found that these eff
Publikováno v:
Journal of Pharmacological Sciences, Vol 131, Iss 4, Pp 292-295 (2016)
A pharmacological approach to ameliorate Alzheimer's disease (AD) has not yet been established. In the present study, we investigated the pharmacological characteristics of the recently identified memory-enhancing compound, ISRIB for the amelioration